The most accessible consumer tVNS device — strong on protocol variety and price, lighter on independent clinical evidence.Best for consumers who want guided neck-worn tVNS with protocol variety, at an accessible price.
Pulsetto is a Lithuanian-made neck-worn tVNS collar that stimulates the cervical vagal branches transcutaneously through two electrode pads. It runs four guided programmes — sleep, stress, anxiety reduction, pain reduction — through a companion app. CE-marked as a wellness device. The clearest entry point into consumer tVNS at the price; the evidence base is mostly company-sponsored and early.
How we tested: Evidence-based assessment — scored from manufacturer specifications, the published Pulsetto pilot record and independent 2026 reviews. Not hands-on tested by ONDA.
+Four guided programmes — broadest protocol variety in the category
+Cheapest neck-worn tVNS at $269
+Companion app logs sessions and tracks self-rated state
+CE-marked; documented pulse parameters
Cons
−Independent clinical evidence is thinner than Nurosym or gammaCore
−Saline/gel pads need regular replacement
−Premium features locked behind Pulsetto+ subscription
−No on-device HRV biofeedback
Price: $269 one-time; optional Pulsetto+ subscription ~$8/mo (as of 2026-05-21)
Where it leads
Pulsetto is the easiest way into consumer cervical tVNS. The neck-worn collar makes daily use simple — no clip to fiddle with, no handheld to hold against the carotid — and the app drives four distinct programmes (sleep, stress, anxiety, pain) instead of asking the user to titrate intensity themselves. At $269 it is also the cheapest cervical device in this list, and the parameters are documented inside the app rather than hidden.
What are the downsides of Pulsetto?
The trade-off is evidence. Most of the supporting research is company-sponsored or in pilot stage; the deeper randomised-trial base belongs to Nurosym and gammaCore. The neck pads need periodic saline or gel-pad replacement, which adds friction. And the more sophisticated features — additional programmes, deeper insights — sit behind the Pulsetto+ subscription, so the $269 ticket understates the full ownership cost a little.
Who should buy Pulsetto?
Choose Pulsetto if you want a polished daily-use cervical tVNS device with structured programmes and minimal setup, and you are comfortable with a lighter independent-evidence base in exchange for accessibility. If the larger (largely maker-funded) trial base is the deciding criterion, Nurosym is the right pick. If you want a one-time-purchase device with no app subscription, Truvaga 350 is closer to that shape.
Background reading
The biology behind what these devices target — and the protocols that compound with the hardware.
Pulsetto is worth it for consumers who want guided neck-worn tVNS at an accessible price. It offers four guided programmes, the broadest variety in its category, and a companion app that logs sessions. Its independent clinical evidence is thinner than Nurosym or gammaCore.
How much does Pulsetto cost?
Pulsetto is listed at $269 one-time, the cheapest neck-worn tVNS device in the review. An optional Pulsetto+ subscription costs about $8 per month and unlocks premium features, and replacement pads are an ongoing cost. Saline or gel pads also need regular replacement.
What are the downsides of Pulsetto?
Pulsetto's independent clinical evidence is thinner than Nurosym or gammaCore, its saline or gel pads need regular replacement, premium features sit behind the Pulsetto+ subscription, and it offers no on-device HRV biofeedback. Its strength is variety and price, not evidence depth.
Pulsetto vs Nurosym: which is better?
Pulsetto is better for price and variety: $269 with four guided programmes and session logging. Nurosym is better for evidence, with the largest independent trial record in consumer tVNS (mostly on earlier Parasym models), but it costs €700 (about $820) and runs a single programme.
